| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/07/2009 | CA2702534A1 A multicomponent or monocomponent vaccine to be used against chagas disease, pharmaceutical compositions containing them, procedure for the obtention of immunogen of said vaccines, and nucleic acid used in said procedure |
| 05/06/2009 | EP2055316A1 Lentivirus vector-based approaches for generating an immune response to HIV in humans |
| 05/06/2009 | EP2055308A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/06/2009 | EP2054515A2 Use of a phage displaying a peptide from an adhesion protein for treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 05/06/2009 | EP1877436A4 Use of mapc or progeny therefrom to populate lymphohematopoietic tissues |
| 05/06/2009 | EP1563092A4 Assays and methods based on microcompetition with a foreign polynucleotide |
| 05/06/2009 | EP1539785B1 Gene regulation in transgenic animals using a transposon-based vector |
| 05/06/2009 | EP1537206B1 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 05/06/2009 | EP1430074B1 Aminoglycoside lipid derivatives for transfection |
| 05/06/2009 | EP1363933B1 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances |
| 05/06/2009 | EP1224271B1 Expression of recombinant mature lysostaphin |
| 05/06/2009 | EP1200114B1 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 05/06/2009 | EP1165114B1 Use of a lectin or conjugates for modulation of c-fibre activity |
| 05/06/2009 | EP1094115B1 (-)-strand rna virus vector for nerve cells |
| 05/06/2009 | CN101427139A Biomarkers for endometrial proliferation |
| 05/06/2009 | CN101426536A Method of treatment, prophylaxis and diagnosis of pathologies of the bone |
| 05/06/2009 | CN101426535A DNA virus microrna and methods for inhibiting same |
| 05/06/2009 | CN101426534A Methods and compositions for detecting and treating retinal diseases |
| 05/06/2009 | CN101423555A Membrane penetrating polypeptide for specific inhibition of hepatitis b virus assembly and replication |
| 05/06/2009 | CN101423517A Gamma-carbolines derivates as well as preparation method and application thereof |
| 05/06/2009 | CN101422620A Cryptosporidum parvum bivalent nucleic acid vaccine and preparation method thereof |
| 05/06/2009 | CN101422619A New method for preventing tumor cell growth based on nucleus binding-protein gene silencing |
| 05/06/2009 | CN101422618A Preparation technique of swine influenza DNA vaccine PLGA microspheres |
| 05/06/2009 | CN101422617A Use of ZNF268 gene splicing isomer in treating leukaemia |
| 05/06/2009 | CN101422616A Gene related to penis induration disease |
| 05/06/2009 | CN101422614A Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 05/06/2009 | CN101422609A Use of lentinan as hepatic C virus nucleic acid vaccine immunologic adjavant |
| 05/06/2009 | CN101422605A Immunoloregulation type DNA vaccine capable of preventing Eimeria necatrix |
| 05/06/2009 | CN101422604A Immunoloregulation type DNA vaccine capable of preventing Eimeria acervulina |
| 05/06/2009 | CN100484575C Chromatin peptide medicinal molecule for sealing MYC cell proliferation path |
| 05/05/2009 | US7528231 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 05/05/2009 | US7528226 TGFβ1-inhibitor peptides |
| 05/05/2009 | US7528224 Human Leucocyte antigen-A2 binding peptide having an amino acid sequence from a signal peptide encoded by the MUC-1 gene; immune reaction against tumor cells further increased by the simultaneous use of cytotoxic T cells directed against both peptides presented by MHC-1 molecules. |
| 05/05/2009 | US7528116 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis |
| 05/05/2009 | US7527966 Expression vector comprising kinase nucleotide sequence for use as tool in transformation and expression of heterologus genes in mamalian cells |
| 05/05/2009 | CA2274116C Use, of an inhibitor of thioredoxin, for inhibiting tumor growth |
| 05/05/2009 | CA2253790C Methods of enhancing anti-tumour immunity in a mammal |
| 05/05/2009 | CA2173338C Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 05/05/2009 | CA2149298C Flk-1 is a receptor for vascular endothelial growth factor |
| 04/30/2009 | WO2009055773A2 Methods for identifying fragile histidine triad (fhit) interaction and uses thereof |
| 04/30/2009 | WO2009055396A1 Induction of pluripotent stem cells into mesodermal lineages |
| 04/30/2009 | WO2009054996A2 Systems and methods for viral therapy |
| 04/30/2009 | WO2009054994A2 Use of compounds activating sirt-3 for mimicking exercise |
| 04/30/2009 | WO2009054470A1 Immune response inducer and use thereof |
| 04/30/2009 | WO2009054321A1 IMMUNOGLOBULIN IgA CLASS SWITCHING AGENT |
| 04/30/2009 | WO2009053982A1 Constructs containing multiple expression cassettes for cancer therapy |
| 04/30/2009 | WO2009053937A2 Nano-lipid-based carriers for targeted delivery of viral vectors and process for its production |
| 04/30/2009 | WO2009052737A1 Medicament for preventing and controlling alzheimer's disease |
| 04/30/2009 | WO2009029681A3 Micrornas for inhibiting viral replication |
| 04/30/2009 | WO2009026155A3 Antimicrobial activity of bovine bactericidal/permeability-increasing protein (bpi) - derived peptides against gram-negative bacterial mastitis isolates |
| 04/30/2009 | WO2009020480A3 Genomic mutation inhibitors that inhibit y family dna polymerases |
| 04/30/2009 | WO2008067025A3 Oncolytic adenoviruses and uses thereof |
| 04/30/2009 | WO2007064952A3 TARGETED PRE-mRNA/mRNA MODIFICATION AND GENE REGULATION |
| 04/30/2009 | WO2007048073A3 Methods and compositions for treatment of cancers with hoxb4 |
| 04/30/2009 | WO2007014370A3 Small regulatory rnas and methods of use |
| 04/30/2009 | WO2006127980A3 Optimized core promoters and uses therefor |
| 04/30/2009 | WO2006080952A3 Improved modalities for the treatment of degenerative diseases of the retina |
| 04/30/2009 | WO2006063252A3 Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering rnas |
| 04/30/2009 | WO2006047638A3 Modulators of epha2 and ephrina1 for the treatment of fibrosis-related disease |
| 04/30/2009 | WO2006017567A3 Customizing stem cell-derived cardiomyocytes for transplantation |
| 04/30/2009 | WO2005120583A3 Method for preventing or treating cardiac hypertrophy |
| 04/30/2009 | WO2005010158A3 Ex vivo methods and compositions for administering a rnai agent to a subject |
| 04/30/2009 | US20090111977 Antisense compound for inducing immunological tolerance |
| 04/30/2009 | US20090111766 Raav vector-based compositions and methods for the prevention and treatment of mammalian diseases |
| 04/30/2009 | US20090111744 Human Growth Gene and Short Stature Gene Region |
| 04/30/2009 | US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex |
| 04/30/2009 | US20090111106 Vector System |
| 04/30/2009 | US20090110684 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 04/30/2009 | US20090110677 Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same |
| 04/30/2009 | US20090110669 Methods for improving cell line activity in immunoisolation devices |
| 04/30/2009 | US20090110661 Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity |
| 04/30/2009 | US20090110643 Method of Producing Liposomes Containing Gas Enclosed Therein |
| 04/30/2009 | DE102008047781A1 Use of an oligopeptide comprising a specific amino acid-sequence for the diagnosis or therapy of a pathological condition in a mammal, preferably human, where the condition is identified by angiogenic processes |
| 04/30/2009 | CA2741403A1 Induction of pluripotent stem cells into mesodermal lineages |
| 04/30/2009 | CA2703774A1 Constructs containing multiple expression cassettes for cancer therapy |
| 04/30/2009 | CA2703707A1 Methods for identifying fragile histidine triad (fhit) interaction and uses thereof |
| 04/29/2009 | EP2053126A1 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 04/29/2009 | EP2052081A1 Fusion proteins and methods for modulation of immune response |
| 04/29/2009 | EP2051988A2 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia |
| 04/29/2009 | EP1454136B1 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 04/29/2009 | EP1407787B1 Method of promoting nucleic acid transfer |
| 04/29/2009 | EP1383540B1 Methods and pharmaceutical compositions for healing wounds |
| 04/29/2009 | EP1267914B1 Use of lysosomal acid lipase for treating atherosclerosis and related diseases |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | EP0934083B1 Improved vaccines |
| 04/29/2009 | EP0835315B1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 04/29/2009 | CN101421293A Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 04/29/2009 | CN101418314A Goat pox vaccine strain expression vector |
| 04/29/2009 | CN101418309A Cloning, expression and application of eimeria tenella protein disulfide isomerase gene |
| 04/29/2009 | CN101417134A Hyaluronic acid decorated novel tertiary structure non-virogene transmission system and use thereof |
| 04/29/2009 | CN100482795C IREN protein, its preparation and use |
| 04/29/2009 | CN100482686C Treatment for diabetes |
| 04/29/2009 | CN100482683C Active fragment of human glycine-rich protein and use thereof |
| 04/29/2009 | CN100482676C N-oxy-group-contained lipids |
| 04/29/2009 | CN100482674C Reduction of dermal scarring |
| 04/29/2009 | CN100482673C Synergisitic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |
| 04/29/2009 | CN100482283C Novel chimeric CD154 |
| 04/28/2009 | US7524949 Prevention or therapy of cardiovascular complications |
| 04/28/2009 | US7524944 polynucleotide encoding peptide domain of CD40 ligand lacking a matrix metalloproteinase cleavage sites, used as immunology modulators, vaccines and treatments of human diseases, including malignancies and autoimmune diseases |
| 04/28/2009 | US7524936 labeled monoclonal or polyclonal antibodies that preferentially binds oxidoreductase enzyme polypeptides, proteins, fragments, domain peptides or amino acid sequences having replacements, capable of superoxide production |